{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:34Z","timestamp":1761894934499,"version":"3.37.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T00:00:00Z","timestamp":1248652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T00:00:00Z","timestamp":1248652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/bmt.2009.176","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T10:43:49Z","timestamp":1248691429000},"page":"498-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["CR represents an early index of potential long survival in multiple myeloma"],"prefix":"10.1038","volume":"45","author":[{"given":"M","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Delasalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Qazilbash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Handy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Alexanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,27]]},"reference":[{"key":"BFbmt2009176_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 1996; 335: 91\u201397.","journal-title":"N Engl J Med"},{"key":"BFbmt2009176_CR2","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"J Child","year":"2003","unstructured":"Child J, Morgan G, Davies F, Owen R, Bell S, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875\u20131883.","journal-title":"N Engl J Med"},{"key":"BFbmt2009176_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ajh.2830330203","volume":"33","author":"R Alexanian","year":"1990","unstructured":"Alexanian R, Barlogie B, Tucker S . VAD-based regimens as primary treatment for multiple myeloma. Am J Hematol 1990; 33: 86\u201389.","journal-title":"Am J Hematol"},{"key":"BFbmt2009176_CR4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood.V80.4.887.887","volume":"80","author":"R Alexanian","year":"1992","unstructured":"Alexanian R, Dimopoulos M, Delasalle K, Barlogie B . Primary dexamethasone treatment of multiple myeloma. Blood 1992; 80: 887\u2013890.","journal-title":"Blood"},{"key":"BFbmt2009176_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1200\/JCO.2003.03.139","volume":"21","author":"D Weber","year":"2003","unstructured":"Weber D, Rankin K, Gavino M, Delasalle K, Alexanian R . Thalidomide alone or with dexamethasone for previously untreated multiple myeloma. J Clin Oncol 2003; 21: 16\u201319.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009176_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/sj.bmt.1703035","volume":"27","author":"R Alexanian","year":"2001","unstructured":"Alexanian R, Weber D, Giralt S, Dimopoulos M, Delasalle K, Smith T et al. Impact of complete remission with intensive therapy in patients with responsive multiple myeloma. Bone Marrow Transplant 2001; 27: 1037\u20131043.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009176_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.bmt.1704562","volume":"34","author":"R Alexanian","year":"2004","unstructured":"Alexanian R, Weber D, Delasalle K, Handy B, Champlin R, Giralt S . Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma. Bone Marrow Transplant 2004; 34: 229\u2013234.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009176_CR8","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, Crowly J, Barlogie B, Blad\u00e9 J et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412\u20133420.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009176_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blade","year":"1998","unstructured":"Blade J, Samson D, Reece D, Apperley J, Bj\u00f6rkstrand B, Gahrton G et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Br J Haematol 1998; 102: 1115\u20131123.","journal-title":"Br J Haematol"},{"key":"BFbmt2009176_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2009176_CR11","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N . Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Rep 1966; 50: 163\u2013170.","journal-title":"Cancer Chemotherapy Rep"},{"key":"BFbmt2009176_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","volume":"1","author":"J Anderson","year":"1983","unstructured":"Anderson J, Cain K, Gelber R . Analysis of survival by tumor response. J Clin Oncol 1983; 1: 710\u2013719.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009176_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"D Cox","year":"1972","unstructured":"Cox D . Regression models and life tables. J Royal Stat Soc 1972; 34: 187\u2013220.","journal-title":"J Royal Stat Soc"},{"key":"BFbmt2009176_CR14","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V95.12.4008","volume":"95","author":"R Desikan","year":"2000","unstructured":"Desikan R, Barlogie B, Sawyer J, Ayers D, Tricot G, Badros A et al. Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood 2000; 95: 4008\u20134010.","journal-title":"Blood"},{"key":"BFbmt2009176_CR15","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1200\/JCO.2005.03.0551","volume":"23","author":"JP Fermand","year":"2005","unstructured":"Fermand JP, Katsahian S, Divine M, Leblond V, Dreyfus F, Macro M et al. High-dose therapy and autologous blood stem cell transplantation compared with conventional treatment in myeloma patients aged 55\u201365 years: long-term results of a randomized control trail from the Group Myeloma-Autogreffe. J Clin Oncol 2005; 23: 9227\u20139233.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009176_CR16","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1200\/JCO.1999.17.7.2173","volume":"17","author":"D Vesole","year":"1999","unstructured":"Vesole D, Crowley S, Catchatourian R, Stiff P, Johnson D, Cromer J et al. High-dose melphalan with autotransplantation for refractory multiple myeloma. J Clin Oncol 1999; 17: 2173\u20132179.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009176_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.bmt.1703717","volume":"30","author":"S Singhal","year":"2002","unstructured":"Singhal S, Powles R, Sirohi B, Treleaven J, Kulkarni S, Mehta J . Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and auto-transplantation in myeloma. Bone Marrow Transplant 2002; 30: 673\u2013679.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009176_CR18","first-page":"161","volume":"34","author":"S Kumar","year":"2004","unstructured":"Kumar S, Lacy MQ, Dispenzieri A, Rajkumar S, Fonseca R, Geyer S et al. High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy. Haematologica 2004; 34: 161\u2013167.","journal-title":"Haematologica"},{"key":"BFbmt2009176_CR19","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMoa032290","volume":"349","author":"M Attal","year":"2003","unstructured":"Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet J et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003; 349: 2495\u20132502.","journal-title":"N Engl J Med"},{"key":"BFbmt2009176_CR20","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1200\/JCO.2007.11.7879","volume":"25","author":"D Dingli","year":"2007","unstructured":"Dingli D, Pacheco J, Nowakowski G, Kumar S, Dispenzieri A, Hayman S et al. Relationship between depth of response and outcome in multiple myeloma. J Clin Oncol 2007; 25: 4933\u20134937.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009176_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbmt.2008.12.512","volume":"15","author":"J Kim","year":"2009","unstructured":"Kim J, Kim K, Cheong J, Min Y, Suh C, Kim H et al. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Biol Blood Marrow Transplant 2009; 15: 463\u2013470.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009176_CR22","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1200\/JCO.2008.17.9721","volume":"26","author":"J Lahuerta","year":"2008","unstructured":"Lahuerta J, Mateos M, Martinez-Lopez J, Rosi\u00f1ol L, Sureda A, de la Rubia J et al. Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival. J Clin Oncol 2008; 26: 5775\u20135782.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009176_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/bmt.2008.166","volume":"42","author":"S Kumar","year":"2008","unstructured":"Kumar S, Dingli D, Dispenzieri A, Lacy M, Hayman S, Buadi F et al. Impact of additional cytoreduction following autologous SCT in multiple myeloma. Bone Marrow Transplant 2008; 42: 259\u2013264.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009176_CR24","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1200\/JCO.2004.05.111","volume":"22","author":"B Durie","year":"2004","unstructured":"Durie B, Jacobson J, Barlogie B, Crowley J . Magnitude of response with myeloma frontline therapy does not predict outcomes. J Clin Oncol 2004; 22: 1857\u20131863.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009176_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/cncr.23546","volume":"113","author":"B Barlogie","year":"2008","unstructured":"Barlogie B, Anaissie E, Haessler J, van Rhee F, Pineda-Roman M, Hollmig K et al. Complete remission sustained for 3 years from treatment initiation is a powerful surrogate marker for extended survival in multiple myeloma. Cancer 2008; 113: 355\u2013359.","journal-title":"Cancer"},{"key":"BFbmt2009176_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1365-2141.2006.06271.x","volume":"135","author":"B Barlogie","year":"2006","unstructured":"Barlogie B, Tricot G, van Rhee F, Angtuaco E, Walker R, Epstein J et al. Long-term outcome results of the first tandem autotransplant trial for multiple myeloma. Br J Haemat 2006; 135: 158\u2013164.","journal-title":"Br J Haemat"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2009176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:49:35Z","timestamp":1739278175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2009176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,27]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["BFbmt2009176"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.176","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2009,7,27]]},"assertion":[{"value":"20 March 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}